As of 2025-10-31, the Relative Valuation of Turning Point Therapeutics Inc (TPTX) is (100.11) USD. This relative valuation is based on P/E multiples. With the latest stock price at 76.01 USD, the upside of Turning Point Therapeutics Inc based on Relative Valuation is -231.7%.
The range of the Relative Valuation is (96.35) - (103.66) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 14.0x - 15.1x | 14.6x |
| Forward P/E multiples | 14.0x - 15.0x | 14.5x |
| Fair Price | (96.35) - (103.66) | (100.11) |
| Upside | -226.8% - -236.4% | -231.7% |
| Date | P/E |